- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vitamin C administration worsens outcomes of sepsis patients on vasopressor therapy: NEJM
USA: In a new study published in The New England Journal of Medicine shows that adults with sepsis following vasopressor therapy in the ICU had a greater risk of death or chronic organ failure at 28 days when receiving intravenous vitamin C compared to those receiving a placebo.
Mixed results have been found in studies examining the effects of intravenous vitamin C in sepsis-affected people undergoing vasopressor therapy in the intensive care unit (ICU). These studies looked at the risk of death and organ failure.
Adults who had been in the intensive care unit (ICU) for no more than 24 hours, had a confirmed or suspected infection as the primary diagnosis, and were taking a vasopressor were randomly assigned to receive an infusion of vitamin C (at a dose of 50 mg per kilogram of body weight) or a matched placebo every six hours for up to 96 hours. On day 28, the primary outcome was defined as a composite of death or persistent organ failure (defined as the need for vasopressors, invasive mechanical ventilation, or new renal replacement therapy).
The key findings of this study were as follow:
1. Randomization was performed on a total of 872 subjects.
2. In the vitamin C group, 191 of 429 patients (44.5%) experienced the primary outcome, while 167 of 434 patients (38.5%) experienced it in the control group.
3. At 28 days, deaths had occurred in 152 of the 429 patients (35.4%) who had received vitamin C and in 137 of the 434 patients (31.6%) who had received a placebo.
4. Persistent organ dysfunction had occurred in 39 of the 429 patients (9.1%) and in 30 of the 434 patients (6.9%) in the vitamin C group and the placebo group, respectively.
5. The results for organ-dysfunction scores, biomarkers, health-related quality of life, 6-month survival, stage 3 acute renal damage, and hypoglycemia episodes were comparable across the two groups.
6. One patient in the vitamin C group experienced a major episode of hypoglycemia, while another experienced a serious anaphylactic reaction.
"The findings of this study suggests that when given to sepsis patients in the intensive care unit, vitamin C was proven to be significantly harmful," said the Authors in conclusion.
Reference:
Lamontagne, F., Masse, M.-H., Menard, J., Sprague, S., Pinto, R., Heyland, D. K., Cook, D. J., Battista, M.-C., Day, A. G., Guyatt, G. H., Kanji, S., McGuinness, S. P., … Adhikari, N. K. J. (2022). Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit. In New England Journal of Medicine. Massachusetts Medical Society. https://doi.org/10.1056/nejmoa2200644
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751